The increase in number of patients suffering from chronic diseases, further fuels the growth of the global STD Testing market.
PORTLAND, OREGON, UNITED STATES, September 13, 2022 /EINPresswire.com/ — The growth of the sexually transmitted diseases market is strongly driven by the high incidence rates and increasing prevalence rates of sexually transmitted diseases such as chlamydia, syphilis and gonorrhea. In addition, the implementation of national screening programs to improve and increase the diagnosis of sexually transmitted diseases in many key geographic areas, such as the ๐๐ง๐ข๐ญ๐๐ ๐๐ญ๐๐ญ๐๐ฌ, ๐๐ง๐ข๐ญ๐๐ ๐๐ข๐ง๐ ๐๐จ๐ฆ ๐๐ง๐ ๐๐๐ง๐๐๐, and the support in reimbursement of STD testing, further support the growth of the test market for sexually transmitted diseases (STDs).
โฆ ๐ ๐จ๐ซ ๐๐ข๐ ๐ก๐ญ ๐๐๐ซ๐ฌ๐ฉ๐๐๐ญ๐ข๐ฏ๐ ๐๐ง๐ ๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ญ: https://www.alliedmarketresearch.com/request-sample/385
However, there is a social stigma associated with patients visiting specialized sexually transmitted disease clinics that prevent patients from being diagnosed with sexually transmitted diseases. In addition, a large percentage of STD patients are located in geographic areas out of reach, significantly limiting the diagnosis of STDs. These factors should hold back the growth of the STD test market.
“Sexually Transmitted Diseases (STD) Testing Market by Disease Type (Chlamydia, Gonorrhea, Herpes Simplex Virus, Syphilis, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), and Other Diseases) and Location of Testing (Laboratory Testing, and Point-of-care (POC) Testing): Global Opportunity Analysis and Industry Forecast, 2021-2030”.
Drivers, restraints, and opportunities –
The high prevalence and incidence of STDs, support for reimbursement of STD testing, and the implementation of national screening programs have fueled the growth of the global STD testing market ( STD). However, the large proportion of STD patients in remote areas, the stringent regulatory compliance requirements for STD market participants, the large number of STD patients in remote areas, and the social stigma associated with visiting patients in sexually transmitted disease clinics hinder market growth. . Rather, the reduction in the number of government clinic visits, national screening programs, and advances in POC testing and technology are expected to open up new opportunities in the future.
๐๐ฌ๐ข๐-๐๐๐๐ข๐๐ข๐, ๐๐จ๐ฅ๐ฅ๐จ๐ฐ๐๐ ๐๐ฒ ๐๐๐๐๐ ๐๐ง๐ ๐๐จ๐ซ๐ญ๐ก ๐๐ฆ๐๐ซ๐ข๐๐, ๐ก๐๐ฅ๐ ๐ญ๐ก๐ ๐ฅ๐ข๐จ๐ง’๐ฌ ๐ฌ๐ก๐๐ซ๐
By region, Asia-Pacific, followed by LAMEA and North America, dominated the market in 2020, contributing to more than half of the market. Moreover, the region is expected to portray the highest CAGR of 5.3% during the forecast period, owing to increase in case of sexual transmitted diseases in emerging countries and rise in patient awareness through education campaigns.
By region, North America is expected to experience market growth at the highest rate, registering a CAGR of 6.4% during the forecast period.
โฆ ๐ ๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ ๐จ๐ ๐๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.alliedmarketresearch.com/purchase-enquiry/385
This report provides comprehensive competitive analysis of Major Key Market Players such as –
Abbott laboratories,
Becton Dickinson Company,
BioMรฉrieux, Inc.,
Bio-Rad Laboratories, Inc.,
Danaher Corporation,
Diasorin Molecular LLC,
Hologic, Inc.,
Orasure Technologies, Inc.,
Roche Holding AG and
Thermo Fisher Scientific Inc.
The gonorrhea segment will manifest the highest until 2030
By disease type, the gonorrhea segment is expected to exhibit the highest CAGR of 7.3% over the forecast period. However, the Chlamydia testing segment dominated the market in 2020, accounting for more than a quarter of the market, due to a lack of awareness of sexually transmitted diseases among the population and a lack of protective barriers. The laboratory test segment dominated the market.
The laboratory testing segment dominated the market
By testing location, the laboratory testing segment made up the lion’s share in 2020, contributing over four-fifths of the market, as the majority of diagnostic testing cases take place in laboratories. However, the point-of-care test segment is expected to record the highest CAGR of 6.3% between 2021 and 2030, due to untapped markets in developing countries.
Key Study Findings –
By intubation, the orotracheal intubation segment held the largest share of the sexually transmitted disease (STD) testing market in 2020 and is expected to remain dominant during the forecast period.
By application, the anesthesia segment held the largest market share in 2020 and is expected to remain dominant during the forecast period.
Per end user, the hospital segment held the largest share of the STD testing market in 2020 and is expected to remain dominant during the forecast period.
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with vario research data tables and confirms utmost accuracy in our market forecasting. Each and ever us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
David Correa
Allied Analytics LLP
800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
You just read:
News Provided By
September 13, 2022, 15:23 GMT
EIN Presswire’s priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content.
As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone’s Internet News Presswireโข,
tries to define some of the boundaries that are reasonable in today’s world. Please see our
Editorial Guidelines
for more information.
Submit your press release
Discovered on: 2022-09-13 15:23:26
Source: Sexually Transmitted Diseases (STD) Testing Market – Is Analyzed Across Nor…
